Patients shown video presentations about prostate and breast cancer screening may change their mind about undergoing the procedure.
Fewer men and women wanted prostate or breast cancer screening after viewing a video regarding the limits and harms associated with the exams, according to a study published in the Annals of Family Medicine.
Researchers from Massachusetts and Washington evaluated novel decision aids designed to help patients trust and accept the controversial, evidence-based, US Preventive Services Task Force recommendations about prostate cancer screening (from 2012) and mammography screening for women aged 40 to 49 (from 2009).
The researchers developed a presentation in which physicians and patients discussed prostate cancer screening and mammography. The presentations included patient/physician discussions and illustrative sides. A crossover study included 27 men (aged 50 to 74) and 35 women (aged 40 to 49) who watched a video intervention or were provided with a more traditional, paper-based decision aid intervention. Each subject was asked about screening intentions, perceptions of benefits and harm, and decisional conflict before and after the intervention.
The results showed that before the interventions, 69% of men and 86% of women had reported wanting screening and 31% and 6%, respectively, were unsure. Mean change on a 3-point, yes, unsure, no scale was −0.93 for men and −0.50 for women after seeing the video interventions versus 0.0 and −0.06 after seeing the print interventions. After the interventions, 33% of men and 49% of women wanted screening, and 11% and 20%, respectively, were unsure.
The researchers concluded that their “persuasive video interventions significantly changed the screening intentions of substantial proportions of viewers. Our approach needs further testing but may provide a model for helping patients to consider and accept evidence-based, counterintuitive recommendations.”
Comparing Digital Breast Tomosynthesis to Digital Mammography: What a Long-Term Study Reveals
September 17th 2024In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.
What New Research Reveals About Digital Mammography and Digital Breast Tomosynthesis
July 31st 2024Digital breast tomosynthesis (DBT) had a significantly higher cancer detection rate (CDR) in comparison to two consecutive post-DBT rounds of digital mammography, according to a new secondary analysis of the Malmo Breast Tomosynthesis Screening Trial (MBTST).